Meyer K B, Skogberg M, Margenfeld C, Ireland J, Pettersson S
Wellcome/CRC Institute of Cancer and Developmental Biology, University of Cambridge, GB.
Eur J Immunol. 1995 Jun;25(6):1770-7. doi: 10.1002/eji.1830250643.
The activity of the immunoglobulin 3' enhancer is restricted to the late stages of B lymphoid development. Here we further examine the molecular basis for the temporally restricted activity of the B-lymphoid IgH 3' enhancer. We demonstrate that a binding site (E5 site) for the E47 and/or E12 proteins is functionally important for enhancer activity. The multimerized E5 site acts as a B cell-specific enhancer and, when assayed in COS cells, can be transactivated by E47/E12 proteins. This transactivation in COS cells, as well as the activity of the full length 3' enhancer in plasma cells, can be repressed by overexpression of the dominant negative nuclear regulator Id3. When examining the tissue distribution of Id3 in murine cell lines, we find that Id3 is expressed throughout the pre-B and B cell stages, but is down-regulated at the plasma cell stage. Thus, Id3 may contribute to the temporal regulation of the IgH 3' enhancer.
免疫球蛋白3'增强子的活性局限于B淋巴细胞发育的后期。在此,我们进一步研究B淋巴细胞IgH 3'增强子时间受限活性的分子基础。我们证明E47和/或E12蛋白的结合位点(E5位点)对增强子活性具有重要功能。多聚化的E5位点可作为B细胞特异性增强子,在COS细胞中进行检测时,可被E47/E12蛋白反式激活。COS细胞中的这种反式激活以及浆细胞中全长3'增强子的活性,可被显性负性核调节因子Id3的过表达所抑制。在检测Id3在小鼠细胞系中的组织分布时,我们发现Id3在整个前B细胞和B细胞阶段均有表达,但在浆细胞阶段表达下调。因此,Id3可能参与了IgH 3'增强子的时间调控。